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Emergence of extensively drug resistant tuberculosis (XDR-TB) is the consequence of
the failure of second line TB treatment. Aminoglycosides are the important second
line anti-TB drugs used to treat the multi drug resistant tuberculosis (MDR-TB). Main
known mechanism of action of aminoglycosides is to inhibit the protein synthesis
by inhibiting the normal functioning of ribosome. Primary target of aminoglycosides
are the ribosomal RNA and its associated proteins. Various mechanisms have been
proposed for aminoglycosides resistance but still some are unsolved. As proteins are
involved in most of the biological processes, these act as a potential diagnostic markers
and drug targets. In the present study we analyzed the purely cytosolic proteome of
amikacin (AK) and kanamycin (KM) resistant Mycobacterium tuberculosis isolates by
proteomic and bioinformatic approaches. Twenty protein spots were found to have over
expressed in resistant isolates and were identified. Among these Rv3208A, Rv2623,
Rv1360, Rv2140c, Rv1636, and Rv2185c are six proteins with unknown functions or
undefined role. Docking results showed that AK and KM binds to the conserved domain
(DUF, USP-A, Luciferase, PEBP and Polyketidecyclase/dehydrase domain) of these
hypothetical proteins and over expression of these proteins might neutralize/modulate
the effect of drug molecules. TBPred and GPS-PUP predicted cytoplasmic nature and
potential pupylation sites within these identified proteins, respectively. String analysis
also suggested that over expressed proteins along with their interactive partners might
be involved in aminoglycosides resistance. Cumulative effect of these over expressed
proteins could be involved in AK and KM resistance by mitigating the toxicity, repression
of drug target and neutralizing affect. These findings need further exploitation for the
expansion of newer therapeutics or diagnostic markers against AK and KM resistance
so that an extreme condition like XDR-TB can be prevented.
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INTRODUCTION
Tuberculosis (TB) still remains one of the deadliest
communicable diseases worldwide which is caused by
Mycobacterium tuberculosis. WHO reported 9.0 million people
developed TB and 1.5 million deaths including 3,60,000 people
with HIV (WHO Report, 2015). Widespread development
of multidrug-resistant tuberculosis (MDR-TB) has worsened
the circumstances and aminoglycosides are used to treat
them. Failure of aminoglycosides anti-TB treatment leads to
resistance as well as emergence of extensively drug resistant
tuberculosis (XDR-TB). Aminoglycosides, amikacin (AK) and
kanamycin (KM) are important second line anti-mycobacterial
drugs for MDR-TB patients. The principle targets of AK and
KM resistance includes mutation in ribosomal protein/16S
rRNA (Beauclerk and Cundliffe, 1987), enzymatic inactivation
of drugs (Welch et al., 2005), decreased inner membrane
transport and active eﬄux pumps (Magnet et al., 2001), cell
wall impermeability (Nikaido, 2003), trapping of drug (Magnet
et al., 2003). AK and KM resistance were contributed by rrs
mutations in approximately 70% M. tuberculosis; however
remaining 30% does not have these mutations and signifying
the contribution of some other resistance mechanism (s).
Advancement in proteomics has cleared the doubts to prove any
complex phenotypes. As proteins marked most of the biological
processes, these are attractive targets for developing new
drugs and diagnostics against the resistance. Two-dimensional
gel electrophoresis (2-DE) coupled with MALDI-TOF-MS
have direct approaches for separation, identification, and
characterization of proteins and its species (Kumar et al.,
2013; Sharma et al., 2015b). Comparative proteomic studies
addressing whole cell lysate and membrane and membrane
associated proteins of aminoglycosides resistance isolates have
been reported (Kumar et al., 2013; Sharma et al., 2015b). Recently
we have reported involvement of ferritin (a cytoplasmic protein)
in AK and KM resistance (Sharma et al., 2016). However,
purely cytosolic expression proteome of aminoglycosides
resistant M. tuberculosis isolates have not been explored.
To address this issue, we analyzed purely isolated cytosolic
proteins of AK and KM resistant M. tuberculosis by direct
proteomic and bioinformatics approaches. Such information
could be helpful for the development of newer diagnostics
and drug targets against AK and KM drug resistance so
that the situations like extensively drug resistance could be
prevented.
MATERIALS AND METHODS
M. tuberculosis Isolates Collection and
Drug Susceptibility Testing
Four total susceptible (rifampicin, isoniazid, ethambutol,
pyrazinamide, streptomycin, kanamycin, and amikacin)
and four AK and KM resistant (sensitive to other first
line and second line drugs) M. tuberculosis isolates were
procured from Mycobacterial Repository Centre of National
JALMA Institute for Leprosy and Other Mycobacterial
Diseases, Agra, India. Drugs susceptibility testing (DST)
for all the drugs was performed by LJ proportion (Canetti
et al., 1969) and REMA methods (Palomino et al., 2002).
Cultures were grown in Sauton’s liquid medium at 37◦C
and harvested in late log phase (4 weeks) for proteomic
analysis.
Purely Cytosolic Proteins Isolation and
Precipitation
Mycobacterial cell lysate was prepared with slight modifications
(Brodie et al., 1979; Sharma and Bisht, 2016). Briefly, Cells
were suspended in sonication buffer with 1% v/v Triton
X-100 and then broken by intermittent sonication at 4◦C
for 20min. Homogenate was centrifuged at 12,000 g for
20min at 4◦C. Resulting supernatants were ultracentrifuged
at 150000 g for 90min. to obtain the purely cytosolic
supernatant and the pellet (cell membrane) was discarded.
Cytosolic supernatant was precipitated using published protocol
(Bisht et al., 2007). Protein concentrations were estimated
by Bradford method (Bradford, 1976). Protein extractions
were performed for three times in biological and technical
replicas.
Two Dimensional Gel Electrophoresis
IEF and SDS-PAGEwere carried out using the published protocol
of “in gel rehydration” with slight modifications (Gorg et al.,
2000; Sharma and Bisht, 2016). In brief, IPG strips of pH
4–7 and length 17 cm (Bio-Rad, Hercules, CA, USA) were
rehydrated overnight at 20◦C with 550µg proteins. Strips were
focused on an IEF unit (Bio-Rad) at 20◦C. Proteins were
separated in second dimension on 12% SDS-polyacrylamide
gels in a vertical electrophoresis unit PROTEAN II XI (Bio-
Rad). Gels were stained with Coomassie Brilliant Blue and
analyzed using PDQuest Advanced software version 8.0.0
(BIORAD, Hercules, CA, USA). Protein spots which showed
consistently increased intensities with more than 1.5 fold were
selected for identification. Student t-test (inbuilt with software)
was used for the statistical analysis by PDQuest Advanced
software. The system picks up the spots with differential
intensity of significant levels built in the system. Equal amount
of protein was loaded in all gels and experiments were
repeated in biological and technical replicates for at least three
times.
In Gel Digestion and Mass Spectrometry
In-gel digestion of proteins andMALDI-TOF/MSwas carried out
using published protocol (Shevchenko et al., 1996; Sharma et al.,
2015b). In brief, mass spectra of digested proteins were acquired
using Autoflex II TOF/TOF 50 (Bruker Daltonik GmbH, Leipzig,
Germany). PMF were submitted to swissprot database for their
identification taking taxonomy as M. tuberculosis complex.
Peptide mass tolerance was set in range of 50–125 ppm (to
acquire the best MASCOT score) with carbamidomethyl-cystein
set as fixed modification. The oxidation of methionine was
set as variable modification and one missed cleavage site was
allowed.
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Bioinformatic Analysis
Protein sequences of hypothetical proteins were retrieved
from Tuberculist server http://tuberculist.epfl.ch/. Classes of
proteins were predicted using TBpred server (Rashid et al.,
2007). There probable functions and interacting partners were
predicted using InterProScan, Molecular docking (Table 3),
GPS-PUP (Quevillon et al., 2005; Schneidman-Duhovny et al.,
2005; Andrusier et al., 2007; Mashiach et al., 2008; Liu
et al., 2011) and STRING analysis (Search Tool for the
Retrieval of Interacting Genes/Proteins, http://string.embl.de/)
(Mawuenyega et al., 2005). STRING-10, server was used to
predict the interacting partners of protein-protein interaction.
STRING database uses a combination of prediction approaches
and an integration of other information (neighborhood,
transferred neighborhood, gene fusion, co-occurrence, co-
expression, experiments, databases, text mining). Network was
made at medium confidence level (0.400) allowing all active
prediction methods.
RESULTS
In this study we have compared the cytosolic protein profiles
of AK and KM resistant (lack rrs mutation) with total
sensitive isolates. 2DE was run in triplicates for all isolates
and composite images are shown in Figure 1. Comparison
of 2D gels by PDQuest Advanced software revealed twenty
protein spots which were consistently over expressed in
resistant as compared to sensitive isolates (cut limit ≥ 1.5
fold changes in spot intensity). For statistical analysis inbuilt
student t-test was used by PDQuest advanced software.
Over expressed proteins spots were identified by MALDI-
TOF-MS (Table 1). The identified proteins were Trigger factor
(Rv2462c), 3-oxoacyl-[acyl-carrier-protein] synthase II (Rv2246),
3-ketoacyl-ACP reductase (Rv0242c), Transcriptional regulator
MoxR1(Rv1479), Fructose-bisphosphate aldolase (Rv0363c),
Universal stress protein (Rv2623), Uncharacterized Protein
(Rv1360), Alkyl hydroperoxide reductase subunit C (Rv2428),
Enoyl-coA hydratase (Rv0632c), Adenylate kinase (Rv0733),
Single stranded DNA-binding protein (Rv0054), Peptidalprolyl
isomerase (Rv0009), Beta carbonic anhydrase 1(Rv1284),
UPF0098 protein (Rv2140c), Hypothetical protein (Rv2185c),
Universal stress protein (Rv1636), Alpha-crystallin/HspX
(Rv2031c), Probable cold shock protein A (Rv3648c), and
Conserved Hypothetical protein (Rv3208A). However, two
spots were identified as a protein of its species and therefore
total 19 proteins were found. Among these Rv2623, Rv1360,
Rv2140c, Rv2185c, Rv1636, and Rv3208A were proteins
of unknown function. Out of nineteen, Rv0363c, Rv1360,
Rv0733, and Rv1284 belonged to intermediary metabolism
and respiration, Rv2623, Rv2428, and Rv1636, Rv2031c, and
Rv3648c to virulence/detoxification/adaptation, Rv2462c to
cell wall and cell processes, Rv2246, Rv0242c, and Rv0632c to
lipid metabolism, Rv2140c, Rv2185c and Rv3208A to conserved
hypothetical, Rv1479 to regulatory proteins and Rv0054
and Rv0009 to information pathway categories. The level of
difference in protein spot intensity has been represented as
densitometric ratio in Table 1. These proteins were also reported
in cytosolic/whole cell lysate fraction of M. tuberculosis complex
by various authors [23–26].
TBPred
TBPred analysis revealed that most of the identified proteins
were found to be predicted in the class of cytoplasmic proteins
(Table 2).
FIGURE 1 | Composite images of 2DE profile of cytosolic proteome of M. tuberculosis isolates (A) Total susceptible (B) AM and KM resistant isolates.
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TABLE 1 | Details of proteins identified by mass spectrometry.
Spot
No.
Accession Protein identified MASCOT Nominal pI Sequence ORF No. Densitometric ratio of Functional
number score mass (Da) coverage % protein intensity between category*
sensitive and resistant isolates
D 1 P9WG55
(TIG_MYCTU)
Trigger factor 78 50586 4.47 33 Rv2462c 1: 3.80 2
D 2 P9WQD7
(FAB2_MYCTU)
3-oxoacyl-[acyl-carrier-protein]
synthase II
133 44250 5.27 35 Rv2246 1: 2.50 7
D 3 O53665
(O53665_MYCTO)
3-ketoacyl-ACP reductase 198 46988 5.86 62 Rv0242c 1: 2.60 7
D 4 Q79FN7
(Q79FN7_MYCTU)
Transcriptional regulator
MoxR1
117 40752 5.96 36 Rv1479 1: 2.20 4
D 5 P9WQA3
(ALF_MYCTU)
Fructose-bisphosphate
aldolase
74 36522 5.49 29 Rv0363c 1: 3.50 1
D 6 P9WFD7
(Y2623_MYCTU)
Universal stress protein 70 31632 5.46 41 Rv2623 1: 1.83 5
D 7 P64831
(Y1360_MYCTU)
Uncharacterized Protein 68 37570 6.38 27 Rv1360 1: 2.50 1
D 8 P9WQB7
(AHPC_MYCTU)
Alkyl hydroperoxide reductase
subunit C
142 21553 4.50 83 Rv2428 1: 2.90 5
D 9 P96907
(P96907_MYCTX)
Enoyl-coA hydratase 79 24281 5.52 57 Rv0632c 1: 3.98 7
D 10 P9WKF5
(KAD_MYCTU)
Adenylate kinase 168 20113 5.02 72 Rv0733 1: 3.60 1
D 11 P9WGD5
(SSB_MYCTU)
Single stranded DNA-binding
protein
86 17343 5.12 40 Rv0054 1: 2.10 3
D 12 P9WHW3
(PPIA_MYCTU)
Peptidalprolyl isomerase 86 19271 5.80 54 Rv0009 1: 2.80 3
D 13 P9WHW3
(PPIA_MYCTU)
Peptidalprolyl isomerase 89 19271 5.80 54 Rv0009 1: 3.10 3
D 14 P9WPJ7
(MTCA1_MYCTU)
Beta carbonic anhydrase 1 117 18177 5.48 45% Rv1284 1: 2.81 1
D 15 P9WFN1
(Y2140_MYCTU)
UPF0098 protein 137 18622 5.41 55 Rv2140c 1: 1.80 6,1
D16 O53519
(O53519_MYCTU)
Hypothetical protein 74 16314 4.75 45 Rv2185c 1: 1.90 6,7
D17 P9WFC9
(Y1636_MYCTU)
Universal stress protein 69 15303 5.51 44 Rv1636 1: 1.72 5
D 18 P9WMK1
(ACR_MYCTU)
Alpha-crystallin 63 16217 5.00 48 Rv2031c 1: 1.83 5
D 19 P9WP75
(CSPA_MYCTU)
Probable cold shock protein A 51 7366 5.17 83 Rv3648c 1: 2.60 5
D 20 Q6MWZ8
(Q6MWZ8_MYCTU)
Conserved Hypothetical
protein
134 9884 4.86 90 Rv3208A 1: 1.90 6
1, intermediary metabolism and respiration; 2, cell wall and cell processes; 3, information pathways; 4, regulatory proteins; 5, virulence, detoxification adaptation; 6, conserved
hypothetical; 7, lipid metabolism.
*Note on functional category.
Interproscan Analysis
InterProScan analysis of Rv3208A showed the presence of
conserved domain (DUF3107) of protein of unknown function
(#PF11305) from residues 1–73. Rv2623 (Universal stress
protein) was found to be highly conserved in mycobacterial
species and it appeared as hypothetical protein with unknown
function. InterProScan analysis of Rv2623 showed the presence
of two conserved USP-A domain with amino acid residues from
10 to 148 and 162–293 (#PF00582). Rv1360 showed conserved
Luciferase like domain from residues 15–316 (#PF00296) and
Rv2140c showed conserved Phosphatidylethanolamine binding
protein (PEBP) domain (#SSF49777) from residues 17–174.
Rv1636 showed the presence of conserved UspA domain with
amino acid residues from 4 to 144 (#PF00582). Rv2185c showed
the presence of Polyketide cyclase/dehydrase domain with amino
acid residues from 4 to 143 (#PF10604).
3D Modeling and Docking
Molecular docking analysis of selected 3D models (showing less
than 2% discrepancy from Ramachandran plot) of hypothetical
proteins was performed to find out their binding sites with
AK and KM. Parameters used for selection of 3D models
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TABLE 2 | Prediction of classes of these identified proteins by TBpred server.
ORF No. Score of amino acid composition Score of dipeptide composition Final predicted class of proteins
based SVM approach based SVM approach
Rv2462c 3.108 1.355 Cytoplasmic
Rv2246 0.927 0.949 Cytoplasmic
Rv0242c 0.704 −0.009 Integral MP/Cytoplasmic
Rv1479 2.402 0.057 Integral MP
Rv0363c 2.062 2.189 Cytoplasmic
Rv2623 1.061 0.549 Cytoplasmic/Integral MP
Rv1360 1.226 0.616 Cytoplasmic
Rv2428 0.417 0.460 Cytoplasmic
Rv0632c 0.676 0.482 Integral MP/Cytoplasmic
Rv0733 4.242 2.154 Cytoplasmic
Rv0054 0.319 −0.496 Attached to Membrane by Lipid Anchor/Secretory
Rv0009 0.553 0.223 Attached to Membrane by Lipid Anchor
Rv1284 1.762 1.515 Cytoplasmic
Rv2140c 0.110 0.081 Integral MP/Cytoplasmic
Rv2185c 3.738 2.543 Cytoplasmic
Rv1636 3.225 0.341 Cytoplasmic
Rv2031c 2.524 2.397 Cytoplasmic
Rv3648c 0.430 1.765 Integral MP/Cytoplasmic
Rv3208A 2.287 1.209 Cytoplasmic
and molecular docking are represented in Table 3. Docking
of Rv3208A (Figure 2) showed the interaction of AK and
KM drugs to the conserved motif of domain of unknown
function (DUF3107 domain). Docking with Rv2623 showed that
both drugs bind to the residues of central cavity of USP-A
domain of universal stress protein (Figure 2). For both drugs
interacting residues were almost common, which suggests similar
binding sites. Docking with Rv1360 (Figure 3) showed that both
drugs bind to the interacting residues of conserved Luciferase
like domain of the uncharacterized protein. Docking with
Rv2140c showed that both drugs interacted with amino acids
residues of conserved PEBP domain of hypothetical UPF0098
protein (Figure 3). Docking analysis of Rv1636 and Rv2185c
(Figure 4) showed that AK and KM binds to conserved USP-A
domain of uncharacterized protein and conserved Polyketide
cyclase/dehydrase domain of hypothetical protein, respectively.
Prediction of Pupylation Sites
Using the default threshold (medium) with cutoff 2.452, GPS-
PUP predicted pupylation sites in 15 identified proteins which
are tabulated in Table 4. Four proteins have not shown any
pupylation sites with these default parameters.
String Analysis
We analyzed the 19 over expressed proteins using STRING-
10 with a medium confidence score threshold of 0.4 and build
an interactome network (Figure 5) for these set of proteins
to find out the protein-protein interaction (PPIs) and predict
functional associations. We found that proteins involved in
intermediary metabolism and respiration, lipid metabolism,
information pathway/regulatory, and virulence, detoxification
and adaptation category interacted with each other as well as their
partners except the hypothetical proteins.
DISCUSSION
In this study we analyzed the comparative cytosolic proteome
of AK and KM resistant isolates by 2DE-MALDI-TOF/MS
and bioinformatic tools. Over expressed proteins in the
resistant clinical isolates were identified, which may be
used as diagnostic markers or drug targets for therapeutics.
2DE/MS has an advantage over the traditional methods (SDS-
PAGE, chromatography and sequencing) as not only the
identification of a large number of unknown proteins but
also protein species separation. Several reports (whole cell
lysates and membrane and membrane associated proteins)
on aminoglycosides drug resistance and identification of
diagnostics/drug targets employing proteomic and bioinformatic
approaches exists (Sharma et al., 2010a, 2014, 2015a,b, 2016;
de Souza et al., 2011; Kumar et al., 2013) which suggested
that over expressed hypothetical proteins (Rv3867, Rv3224,
Rv0148,Rv2744c), universal stress protein (Rv2005c) and some
known proteins (involved in various pathways) might be
involved in aminoglycosides resistance. However, to the best of
our knowledge, no study on cytosolic proteome analysis with AK
and KM resistantM. tuberculosis isolates has been reported.
Repression of Targets
Rv0363c (Fructose bisphosphate aldolase) is centrally involved
in glycolysis, gluconeogenesis, and ATP synthesis. Mycobacteria
reside in specialized niches and may require adaptations in the
energy metabolism. It is essential for growth/pathogenesis of
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TABLE 3 | Modeling, docking parameters and analysis of interacting amino acids to drugs.
ORF TM-score RMSD Drug Global Attractive vander Repulsive vander ACE Interacting Remarks
No. value (Å) energy wall forces wall forces amino acids
Rv3208A 0.37 ± 0.12 10.5 ± 4.6Å AK −24.82 18.86 11.20 −8.52 45–50, 69–72,74, 90 AK binds to
conserved domain
(DUF3107) of
unknown function
Rv3208A 0.37 ± 0.12 10.5 ± 4.6Å KM −26.40 −16.16 3.07 −6.03 26, 30, 40, 42, 52, 53,
86, 88, 89
KM binds to
conserved domain
(DUF3107) of
unknown function
Rv2623 0.95 ± 0.05 2.9 ± 2.1Å AK −55.14 −23.38 7.83 −17.58 167, 198, 261–263,
267–269, 272,
274–278
AK binds into
central cavity of
conserved USP-A
domain
Rv2623 0.95 ± 0.05 2.9 ± 2.1Å KM −53.96 −23.57 2.53 −13.96 167, 198, 245, 262,
263, 265, 267–269,
272, 274–277
KM also binds into
central cavity of
conserved USP-A
domain
Rv1360 0.88 ± 0.07 4.0 ± 2.7Å AK −51.96 −21.77 6.16 −15.20 99,110, 170–172, 174,
175, 188, 189, 196,
199, 252, 253, 255,
257, 258, 295
AK interact to
conserved
Luciferase like
domain of
uncharacterized
protein
Rv1360 0.88 ± 0.07 4.0 ± 2.7Å KM −48.15 −21.32 3.57 −12.25 63, 64, 96, 98–00,
168–70, 174, 186–188,
223, 252, 253, 255
KM also interact to
conserved
Luciferase like
domain of of
uncharacterized
protein
Rv2140c 0.97 ± 0.05 1.7 ± 1.4Å AK −41.65 −17.05 5.19 −15.42 7, 11, 12, 67, 75, 78,
153, 156, 157, 160
AK binds to PEBP
domain of
hypothetical
UPF0098 protein
Rv2140c 0.97 ± 0.05 1.7 ± 1.4Å KM −42.41 −17.98 5.47 −14.14 7, 8, 11, 12, 67, 69,
75, 78, 153, 156, 157,
160, 166
KM binds to PEBP
domain of
hypothetical
UPF0098 protein
Rv1636 0.80 ± 0.09 3.4 ± 2.4Å AK −26.95 −13.46 0.95 −9.50 114, 115, 121–125,
144–146
AK binds to binds
to conserved
USP-A domain of
uncharacterized
protein
Rv1636 0.80 ± 0.09 3.4 ± 2.4Å KM −33.03 −14.91 7.87 −11.76 41, 42, 44, 94,
115–118, 123,
126–128
KM binds to binds
to conserved
USP-A domain of
uncharacterized
protein
Rv2185c 0.82 ± 0.09 3.2 ± 2.3Å AK −45.57 −23.23 14.30 −13.91 28, 32, 35, 50, 54, 63,
65, 67, 69, 80, 88, 95,
108, 110, 123, 127,
130, 131, 134, 138
AK binds to
conserved
Polyketide
cyclase/
dehydrase domain
of hypothetical
protein
Rv2185c 0.82 ± 0.09 3.2 ± 2.3Å KM −41.48 −17.75 2.17 −10.55 32, 34, 35, 54, 56, 63,
65, 80, 91, 95, 108,
110, 112, 123, 127,
130, 131, 134
KM binds to
conserved
Polyketide
cyclase/
dehydrase domain
of hypothetical
protein
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FIGURE 2 | 3D model of hypothetical proteins showing docking with AK and KM. (A1,A2) shows molecular docking of Rv3208A with AM (blue) and KM (red),
respectively, yellow color shows interacting residues of DUF3107 domain. (B1,B2) shows molecular docking of Rv2623 with AM (blue) and KM (red), respectively,
yellow color show interacting residues of USP-A domain.
replicating and dormant M. tuberculosis (de la Paz Santangelo
et al., 2011). Puckett et al. suggested that it regulates glycolytic
and gluconeogenic carbon co-catabolism in M. tuberculosis
(Puckett et al., 2014). Aminoglycosides resistant mycobacteria
also behave like dormant bacilli due to repression of targets.
Low translational state is an intrinsic defense mechanism
of aminoglycosides resistant mycobacteria. Over expression
of Rv0363c might maintain energy supply to resistant
M. tuberculosis. Rv0733 (Adenylate kinase) is a small ubiquitous
enzyme involved in ATP metabolism. Meena et al. suggested that
Rv0733 has dual activity as nucleoside mono—and diphosphate
kinase and could be implicated in the purine salvage pathway
(Meena et al., 2003). Recently Lata et al. reported that Rv0733
is over expressed in ofloxacin mono resistant M. tuberculosis
(Lata et al., 2015b). Over expression of Rv0733 maintains
nucleotide supply to cells even in low translational state or
dormant state and act as attractive targets for the development
of new antimycobacterial agents. Rv1284 (β-carbonic anhydrase)
catalyzes the reversible hydration of carbon dioxide to form
bicarbonate and is also needed for fatty acid biosynthesis as
well as pH homeostasis, therefore it is considered as essential
for survival of M.tuberculosis. Rv1284 gene was highly over
expressed under nutrients starved condition (Betts et al., 2002).
Nienaber et al. reported Tyr120 of Rv1284 is critical residue for
oxidative inactivation and its involvement in pH homeostasis/
redox-regulation (Nienaber et al., 2015). Over expression of
Rv1284 might be involved in pathogenesis by maintaining the
homeostasis/biosynthesis of fatty acids. Rv1479 (Transcriptional
regulator MoxR1) is involved in regulatory function. Hu and
Coates reported that its m-RNA was 4-fold over expressed in
persisters as compared to stationary phase of mycobacteria
(Hu and Coates, 2001). Recently Sharma et al. reported it’s
over expression in aminoglycosides resistant M. tuberculosis
(Sharma et al., 2015b). Aminoglycosides resistant mycobacteria
also behave like dormant bacilli due to repression of targets
which is the mycobacterial intrinsic defense mechanism
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FIGURE 3 | 3D model of hypothetical proteins showing docking with AK and KM. (C1,C2) shows docking of Rv1360 with AM (blue) and KM (red), respectively,
yellow color shows interacting residues of luciferase like domain. (D1,D2) shows docking of Rv2140c with AM (blue) and KM (red), respectively, yellow color shows
interacting residues of conserved PEBP domain of hypothetical UPF0098 protein.
against resistance. Our study assumes that over expression
of this protein regulate the transcription of mycobacteria
even in low transcriptional state or dormant state. Rv0009
(Probable iron-regulated peptidyl prolyl cis–trans isomerase
A) is probably involved in cis-trans isomerization of proline
imidic peptide bonds in oligopeptides and accelerated protein
folding (Henriksson et al., 2004). Recently Lata et al. reported
the higher expression of Rv0009 in ofloxacin and moxifloxacin
induced M. tuberculosis (Lata et al., 2015a). Over expression of
Rv0009 might maintain cis-trans isomerization of amino acids
and its supply to cells even in low translational state or dormant
state.
We hypothesized that over expression of Rv0363c, Rv0733,
Rv1284, Rv1479, and Rv0009 proteins might cumulatively
overcome the effect of targets repression and contribute to
aminoglycosides resistance.
Mitigate the Toxicity
Rv2462c (trigger factor, also acts as chaperone), is not only
involved in protein export but also maintains the open
conformation of newly synthesized protein. It was reported
that its intensity is regulated by phosphate depletion (Rifat
et al., 2009). Sharma et al. reported that it was over expressed
in aminoglycosides resistant M. tuberculosis (Sharma et al.,
2015b). Over expression of Rv2462c might mitigate the toxicity
by maintaining the export of newly synthesized protein or
truncated proteins in an open conformation. Rv2031c (Alpha-
crystallin/HspX), protect the cells from different stimuli like
stress, dormancy, drug and hypoxia by preventing protein
aggregation (Sherman et al., 2001). In our previous studies,
increased intensity of Rv2031c was reported in resistant
M. tuberculosis (Kumar et al., 2013; Sharma et al., 2015b). Over
expression of Rv2031c might mitigate the toxicity by preventing
protein aggregation. Rv3648c (probable cold shock protein A)
possibly involved in cold acclimation processes like dormancy,
stress, drug and hypoxia (Hu et al., 1999). Rv3648c mRNA
showed five to sevenfold increase in Mycobacterium smegmatis
under cold-induction dormancy (Shires and Steyn, 2001). Over
expression of Rv3648c might mitigate the aminoglycosides
toxicity by maintaining the protein conformation. Rv2428
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FIGURE 4 | 3D model of hypothetical proteins showing docking with AK and KM. (E1,E2) shows docking of Rv1636 with AM (blue) and KM (red), respectively,
yellow color shows interacting residues of conserved USP-A domain, (F1,F2) shows docking of Rv2185c with AM (blue) and KM (red), respectively, yellow color
shows interacting residues of conserved Polyketide cyclase/dehydrase domain of hypothetical protein.
(Alkyl hydroperoxide reductase C/AhpC), a novel group of
the peroxiredoxin family that reduces organic peroxide and
hydrogen peroxides. Heym et al. reported that over expression
of the AhpC involved in virulence and isoniazid resistance of
M. tuberculosis (Heym et al., 1997). Lee et al. suggested that AhpC
expression was induced under oxidative stress conditions and
involved in M. smegmatis (Lee et al., 2014). Over expression of
Rv2428 might mitigate the toxic effects of the aminoglycosides.
Rv0054 (SS-DNA binding protein/SSB) involved to maintain
DNA/RNA integrity in replication, recombination and repair
phenomena. SSBs are also involved in modulating the activity
of DNA polymerase, RNA polymerase and DNA helicase. Over
expression of Rv0054 was found in drug induced study (Lata
et al., 2015a). Over expression of Rv0054 might mitigate the
toxicity/stress of drugs. Rv2246 (3-oxoacyl-[acyl-carrier protein]
synthase 2) was involved in meromycolate elongation step of
mycolic acid biosynthetic pathway (Singh et al., 2011) which
provides a thick layer of lipid in the cell wall and protects
M. tuberculosis from environmental and poisonous chemicals
stress. Starck et al. reported that in M. tuberculosis Rv2246
was over expressed under anaerobic conditions (Starck et al.,
2004). Over expression of Rv2246 might mitigate the toxicity
of aminoglycosides. Rv0242c (Probable 3-oxoacyl-[acyl-carrier
protein] reductase/FabG4) is involved in the first step of fatty
acid biosynthesis pathway. Beste et al. suggested fabG4 to be
essential for growth of M. bovis BCG on Roisin’s medium (Beste
et al., 2009). Sharma et al. suggested that Rv0242c might play
a role in altering the drug permeability in resistant isolate by
changing the fatty acid composition of the cell envelope (Sharma
et al., 2010a). Over expression of Rv0242c might mitigate
the toxicity of aminoglycosides. Rv0632c (Probable enoyl-CoA
hydratase/EchA3) could possibly oxidize fatty acids. Maurya
et al. reported that Rv0632c was overexpressed under anaerobic
culture condition (Maurya et al., 2014). Recently Vargas-Romero
et al. suggested that over expression of Rv0632c in hyper virulent
M. tuberculosis CPT31 could facilitate mycobacterial infection
and persistence (Vargas-Romero et al., 2016). Over expression of
Rv0632c might mitigate the toxic effects of aminoglycosides.
We hypothesized that over expression of Rv2462c, Rv2031c,
Rv3648c, Rv2428, Rv0054, Rv2246, Rv0242c, and Rv0632c
proteins might cumulatively mitigate the toxicity and contribute
to aminoglycosides resistance.
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TABLE 4 | Predicted/identified pupylation sites within identified proteins.
ORF No. Position of Peptides Score Cut-off
lysine residue
undergoes pupylation
Rv2462c 2 ******VKSTVEQLS 2.614 2.452
33 PDFQRAYKELAKQVR 3.394 2.452
274 SDQVRQAKRAQQAEQ 2.669 2.452
439 DTSEFFGKRVSAGEA 2.677 2.452
Rv2246 54 TDAETTWKLLLDRQS 2.543 2.452
164 VSPLTVQKYMPNGAA 2.795 2.452
Rv0242c 100 ITEPAGLKGLHEFFT 2.591 2.452
150 GFTRSLGKELRRGAT 2.472 2.452
168 VYLSPDAKPAATGLE 3.827 2.452
381 LAPGLAAKGITINAV 3.323 2.452
Rv1479 71 MLVGLLSKGHVLLEG 2.646 2.452
Rv0363c 149 AIAQELLKAAAAAKI 3.669 2.452
155 LKAAAAAKIILEIEI 3.016 2.452
189 TSPEDFEKTIEALGA 3.165 2.452
318 YDPRSYLKKAEASMS 2.52 2.452
Rv2623 35 ARDAELRKIPLTLVH 3.63 2.452
Rv2428 25 LIGGDLSKVDAKQPG 4.071 2.452
70 TEIAAFSKLNDEFED 3.11 2.452
192 LDAGELLKASA**** 6.024 2.452
Rv0733 23 QAVKLAEKLGIPQIS 4.26 2.452
94 PRSVEQAKALHEMLE 5.756 2.452
181 RALRALGK******* 5.866 2.452
Rv0054 84 VIVSGRLKQRSFETR 2.866 2.452
95 FETREGEKRTVIEVE 2.945 2.452
Rv0009 133 QFFITVGKTPHLNRR 2.646 2.452
161 RVVEAISKTATDGND 2.772 2.452
Rv2140c 133 QFFITVGKTPHLNRR 2.646 2.452
Rv2185c 89 LESSSLLKSLEGTYR 3.079 2.452
136 RLIDGALKDLKKRVE 3.236 2.452
139 DGALKDLKKRVEG** 2.803 2.452
140 GALKDLKKRVEG*** 3.496 2.452
Rv2031c 64 LPGVDPDKDVDIMVR 2.669 2.452
85 KAERTEQKDFDGRSE 2.748 2.452
114 GADEDDIKATYDKGI 3.386 2.452
119 DIKATYDKGILTVSV 2.913 2.452
132 SVAVSEGKPTEKHIQ 3.433 2.452
Rv3648c 47 RTLEENQKVEFEIGH 3.236 2.452
57 FEIGHSPKGPQATGV 2.591 2.452
Rv3208A 85 AAAGSAGKVATSG** 4.126 2.452
Bold letter “K” means it undergoes pupylation.
* It is the blank space where no amino acid occurs.
Neutralizing Effect
Rv2623 and Rv1636 are universal stress proteins with unknown
function. These were over-expressed under nutrient/oxygen
limitation and be involved in virulence/chronic infection
(Stewart et al., 2001). Recently Lata et al. reported that Rv2623
and Rv1636 were over expressed in ofloxacin and moxifloxacin
induced study (Lata et al., 2015a). In the present study we
have observed that AK and KM interacted to the residues of
conserved USP-A domains of Rv2623 and Rv1636, which might
be altering the functions. It is suggested that over expression of
these proteins might neutralize/compensate the effect of drugs.
Rv1360 (probable oxidoreductase) is an uncharacterized protein,
probably involved in cellular metabolism. Kruh et al. reported
that Rv1360 was expressed in guinea pig model during early and
chronic stages of disease (Kruh et al., 2010). The bacteria are
thought to be in a state of reduced replication and metabolism
as part of the chronic lung infection as well as in aminoglycosides
resistance; therefore over expression of Rv1360 might maintain
the replication and metabolism. Through in-silico approaches
Raman and Chandra suggested that it is a potential drug target
against tuberculosis (Raman and Chandra, 2008). In the present
study we have observed that AK and KM interacted to the
residues of conserved Luciferase like domain, which might be
altering the functions. Rv2140c (UPF0098 protein/conserved
hypothetical protein/TB18.6) is the protein of unknown function.
It is reported that Rv2140c had a phosphatidyl ethanolamine-
binding protein (Eulenburg et al., 2013). Recently Lata et al.
reported that Rv2140c was over expressed in ofloxacin resistant
M. tuberculosis (Lata et al., 2015b). In the present study we
have observed that AK and KM interacted to the residues of
conserved Phosphatidylethanolamine binding protein (PEBP)
domain, which might be altering the functions. Rv2185c
(Conserved hypothetical protein/TB16.3) is the protein of
unknown function. Starck et al. reported that in M. tuberculosis
Rv2185c was over expressed under anaerobic conditions (Starck
et al., 2004). It is reported that over expression of Rv2185c
induced IκBα degradation and nuclear translocation of NFκB
(Zhang et al., 2015). In the present study we have observed that
AK and KM interacted to the residues of conserved Polyketide
cyclase/dehydrase domain, which might alter the function.
Rv3208A (Conserved hypothetical protein/TB 9.4) is the protein
of unknown function. Griffin et al. suggested that expression of
Rv3208A is essential for M. tuberculosis growth and cholesterol
catabolism (Griffin et al., 2011). In our study we have found that
AK and KM interacted to the residues of conserved DUF3107
domain, which might alter the function.
We hypothesized that over expression of Rv2623, Rv1636,
Rv1360, Rv2140c, Rv2185c, and Rv3208A hypothetical proteins
might cumulatively neutralize/compensate the effect of drugs and
contribute to aminoglycosides resistance.
Pupylation is a reversible PTM which is likely to have a
regulatory role (Burns et al., 2010). Pupylation contributes
to the virulence/survival strategy of M. tuberculosis in the
host and makes the bacteria more resistant to drug and
other stresses (Darwin et al., 2003). In our study, out of
19 over expressed proteins 15 showed the pupylation sites
which suggested that over expression of these proteins via
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FIGURE 5 | STRING analysis reveals the interaction partners of the over expressed proteins which showed that over expressed proteins interacted to
proteins of the similar functional categories except the hypothetical proteins.
Pup-proteasome system (protein-protein interaction) might
be involved in proteins turnover to overcome aminoglycosides
stress. Interactome revealed that overexpressed proteins of lipid
metabolism (LM), intermediary metabolism and respiration
(IMR), information pathway/regulatory proteins (IP/RP),
and virulence, detoxification and adaptation (VDA) category
interacted to the other proteins which were involved in pathways
of LM, IMR, IP/RP and VDA categories. We suggested that over
expressed proteins along with their interactive partners of these
various functional categories might cumulatively be involved in
aminoglycosides resistance.
We assume that over expressed proteinsmight be contributing
in AK and KM resistance and might act as diagnostic
marker or potential targets for drug development against
resistance.
CONCLUSION
In a nutshell, in this report we focus on the purely cytosolic
proteins of AK and KM resistantM. tuberculosis using proteomic
and bioinformatic approach. Among the 19 over expressed
proteins, 13 with their defined roles and six with unknown
functions. TBpred predicted most of the proteins belong to
cytoplasmic class. Molecular docking of these six hypothetical
proteins (Rv2623, Rv1636, Rv1360, Rv2140c, Rv2185c, and
Rv3208A) showed that AK and KM interacted to their conserved
domains. GPS-PUP predicted presence of pupylation sites within
15 proteins. Interactome also suggested that over expressed
proteins interacted with each other and their partners except the
hypothetical proteins. It is depicting that over expression of these
proteins might not only neutralize/ modulate the effect of drug
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molecules but also are involved in various mechanisms, such as
in mitigating the toxicity, repression of drug target and protein
turnover to overcome the AK and KM resistance. We assume
that cumulative effect of these over expressed proteins might
be responsible to AK and KM resistance. These findings need
further exploitation for the development of newer therapeutic
agents or molecular markers which can directly be targeted to
a gene/protein responsible for resistance so that an extreme
condition like XDR-TB can be prevented and which could
ultimately lead to exploration of newer therapeutics.
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